Trademark: 97522048
Word
CELLICON VALLEY
Status
Pending
Status Code
730
Status Date
Friday, November 17, 2023
Serial Number
97522048
Mark Type
4000
Filing Date
Wednesday, July 27, 2022
Published for Opposition
Tuesday, May 16, 2023

Trademark Owner History

Classifications
40 Manufacturing services for others in the fields of pharmaceutical preparations, biopharmaceutical preparations, biologics, drug products, DNA plasmids, advanced therapeutic medicinal products (ATMPs), principally cell and gene therapies intended for research, clinical and commercial use in humans for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; manufacturing process consulting; production of cell lines for others using lentivirus technology
45 Regulatory compliance consulting in the fields of pharmaceuticals, medicines, biopharmaceuticals, and gene therapy
42 Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; research and development of new products for others; process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; scientific research and technical research services in the field of production of cell lines for others using lentivirus technology; scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and ยท manufacturing; quality control for others; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; material testing; product quality testing; scientific laboratory services; scientific research

Trademark Events
Nov 21, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 17, 2023
Sou Extension 1 Granted
Nov 17, 2023
Sou Extension 1 Filed
Nov 17, 2023
Sou Teas Extension Received
Jul 11, 2023
Noa E-Mailed - Sou Required From Applicant
May 16, 2023
Official Gazette Publication Confirmation E-Mailed
May 16, 2023
Published For Opposition
Apr 26, 2023
Notification Of Notice Of Publication E-Mailed
Apr 13, 2023
Approved For Pub - Principal Register
Apr 12, 2023
Teas/Email Correspondence Entered
Apr 12, 2023
Correspondence Received In Law Office
Apr 12, 2023
Teas Response To Office Action Received
Mar 28, 2023
Notification Of Non-Final Action E-Mailed
Mar 28, 2023
Non-Final Action E-Mailed
Mar 28, 2023
Non-Final Action Written
Mar 27, 2023
Assigned To Examiner
Aug 18, 2022
New Application Office Supplied Data Entered
Jul 30, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24